Roopa Industries Limited (ROOPAIND.BO)
INR 76.5
(-0.57%)
INR 76.5
(-0.57%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 493.08 Million INR | 15.73% |
| 2022 | 426.05 Million INR | 16.92% |
| 2021 | 364.4 Million INR | 4.81% |
| 2020 | 347.66 Million INR | 26.91% |
| 2019 | 273.93 Million INR | 5.18% |
| 2018 | 260.44 Million INR | 2.11% |
| 2017 | 255.05 Million INR | 31.2% |
| 2016 | 194.4 Million INR | 19.83% |
| 2015 | 162.24 Million INR | -3.82% |
| 2014 | 168.69 Million INR | 9.75% |
| 2013 | 153.7 Million INR | 19.59% |
| 2012 | 128.52 Million INR | 18.66% |
| 2011 | 108.31 Million INR | -6.17% |
| 2010 | 115.43 Million INR | 15.36% |
| 2009 | 100.06 Million INR | 39.5% |
| 2008 | 71.72 Million INR | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 Q3 | - INR | -100.0% |
| 2023 Q4 | 493.08 Million INR | 0.0% |
| 2023 FY | 493.08 Million INR | 15.73% |
| 2023 Q1 | - INR | -100.0% |
| 2023 Q2 | 438.33 Million INR | 0.0% |
| 2022 Q3 | - INR | -100.0% |
| 2022 FY | 426.05 Million INR | 16.92% |
| 2022 Q2 | 448.36 Million INR | 0.0% |
| 2022 Q4 | 426.05 Million INR | 0.0% |
| 2022 Q1 | - INR | -100.0% |
| 2021 Q4 | 364.4 Million INR | 0.0% |
| 2021 FY | 364.4 Million INR | 4.81% |
| 2021 Q3 | - INR | -100.0% |
| 2021 Q2 | 373.78 Million INR | 0.0% |
| 2021 Q1 | - INR | -100.0% |
| 2020 FY | 347.66 Million INR | 26.91% |
| 2020 Q2 | 295.04 Million INR | 0.0% |
| 2020 Q3 | - INR | -100.0% |
| 2020 Q4 | 347.66 Million INR | 0.0% |
| 2020 Q1 | - INR | -100.0% |
| 2019 FY | 273.93 Million INR | 5.18% |
| 2019 Q1 | - INR | -100.0% |
| 2019 Q3 | - INR | -100.0% |
| 2019 Q2 | 258.77 Million INR | 0.0% |
| 2019 Q4 | 273.93 Million INR | 0.0% |
| 2018 FY | 260.44 Million INR | 2.11% |
| 2018 Q4 | 260.44 Million INR | 0.0% |
| 2018 Q3 | - INR | -100.0% |
| 2018 Q2 | 228.29 Million INR | 0.0% |
| 2018 Q1 | - INR | -100.0% |
| 2017 Q2 | 227.69 Million INR | 0.0% |
| 2017 Q3 | - INR | -100.0% |
| 2017 Q4 | 256.74 Million INR | 0.0% |
| 2017 FY | 255.05 Million INR | 31.2% |
| 2016 Q1 | - INR | -100.0% |
| 2016 FY | 194.4 Million INR | 19.83% |
| 2016 Q2 | 189.4 Million INR | 0.0% |
| 2016 Q4 | 194.93 Million INR | 0.0% |
| 2016 Q3 | - INR | -100.0% |
| 2015 Q1 | - INR | -100.0% |
| 2015 Q2 | 173.37 Million INR | 0.0% |
| 2015 FY | 162.24 Million INR | -3.82% |
| 2015 Q4 | 162.24 Million INR | 0.0% |
| 2015 Q3 | - INR | -100.0% |
| 2014 Q3 | - INR | -100.0% |
| 2014 Q2 | 182.74 Million INR | 0.0% |
| 2014 FY | 168.69 Million INR | 9.75% |
| 2014 Q1 | - INR | -100.0% |
| 2014 Q4 | 168.69 Million INR | 0.0% |
| 2013 Q4 | 153.7 Million INR | 0.0% |
| 2013 FY | 153.7 Million INR | 19.59% |
| 2013 Q2 | 147.78 Million INR | 0.0% |
| 2013 Q1 | - INR | -100.0% |
| 2013 Q3 | - INR | -100.0% |
| 2012 Q4 | 128.52 Million INR | 0.0% |
| 2012 FY | 128.52 Million INR | 18.66% |
| 2011 FY | 108.31 Million INR | -6.17% |
| 2011 Q4 | 108.31 Million INR | 0.0% |
| 2010 FY | 115.43 Million INR | 15.36% |
| 2009 FY | 100.06 Million INR | 39.5% |
| 2008 FY | 71.72 Million INR | 0.0% |
| 2008 Q4 | 71.72 Million INR | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Hindustan Bio Sciences Limited | 25.7 Million INR | -1818.547% |
| KIMIA BIOSCIENCES LIMITED | 996.35 Million INR | 50.511% |
| SHELTER PHARMA LIMITED | 20.99 Million INR | -2249.152% |
| Vasundhara Rasayans Limited | 53.64 Million INR | -819.132% |
| Sunil Healthcare Limited | 902.83 Million INR | 45.384% |
| Chemo Pharma Laboratories Limited | 2.12 Million INR | -23071.382% |
| MedPlus Health Services Limited | 14.27 Billion INR | 96.546% |
| Bharat Immunologicals & Biologicals Corporation Limited | 1 Billion INR | 50.904% |
| Patidar Buildcon Limited | 25.57 Million INR | -1828.23% |
| Smruthi Organics Limited | 485.72 Million INR | -1.517% |
| Trident Lifeline Limited | 331.26 Million INR | -48.851% |
| PANJON LTD. | 25.38 Million INR | -1842.588% |
| Pharmaids Pharmaceuticals Limited | 208.44 Million INR | -136.56% |
| Gujarat Terce Laboratories Limited | 161.67 Million INR | -204.988% |
| TIAAN CONSUMER LIMITED | 14.97 Million INR | -3191.855% |
| Anuh Pharma Limited | 1.54 Billion INR | 68.077% |
| Crestchem Limited | 23.94 Million INR | -1959.076% |
| Emmessar Biotech & Nutrition Limited | 13.4 Million INR | -3578.381% |
| Sandu Pharmaceuticals Limited | 118.22 Million INR | -317.082% |
| Tyche Industries Limited | 101.64 Million INR | -385.126% |
| Fredun Pharmaceuticals Limited | 1.86 Billion INR | 73.508% |
| Trimurthi Limited | 101.36 Thousand INR | -486370.994% |
| Shukra Pharmaceuticals Limited | 201.97 Million INR | -144.134% |
| Norris Medicines Limited | 278.17 Million INR | -77.259% |
| Zenlabs Ethica Limited | 301.35 Million INR | -63.624% |
| Vikram Thermo (India) Limited | 291.47 Million INR | -69.169% |
| ANG Lifesciences India Limited | 1.66 Billion INR | 70.325% |
| Parmax Pharma Limited | 117.56 Million INR | -319.407% |
| Veerhealth Care Limited | 62.78 Million INR | -685.421% |
| Deccan Health Care Limited | 111.33 Million INR | -342.882% |
| SUDARSHAN PHARMA INDUSTRIES LI | 1.71 Billion INR | 71.235% |
| Makers Laboratories Limited | 569.18 Million INR | 13.369% |
| Lactose (India) Limited | 536.39 Million INR | 8.074% |
| OXYGENTA PHARMACEUTICAL LIMITE | 833.14 Million INR | 40.816% |
| Zenith Healthcare Limited | 24.03 Million INR | -1951.537% |
| Sanjivani Paranteral Limited. | 155.06 Million INR | -217.987% |
| Bacil Pharma Limited | 1.12 Million INR | -43574.668% |
| PRAVEG LIMITED | 767.53 Million INR | 35.757% |
| Denis Chem Lab Limited | 289.82 Million INR | -70.134% |
| Kwality Pharmaceuticals Limited | 1.71 Billion INR | 71.27% |
| Jenburkt Pharmaceuticals Limited | 201.59 Million INR | -144.597% |
| Colinz Laboratories Limited | 24.1 Million INR | -1945.58% |
| Godavari Drugs Limited | 957.86 Million INR | 48.522% |
| SHAMROCK INDUSTRIAL CO.LTD. | 299 Thousand INR | -164812.04% |
| Zenotech Laboratories Limited | 156.64 Million INR | -214.774% |
| Panchsheel Organics Limited | 340.2 Million INR | -44.939% |
| Shree Ganesh Remedies Limited | 488.36 Million INR | -0.966% |
| Vivanza Biosciences Limited | 148.63 Million INR | -231.752% |
| Phaarmasia Limited | 211.49 Million INR | -133.144% |
| Sastasundar Ventures Limited | 1.5 Billion INR | 67.14% |
| Medi-Caps Limited | 63.01 Million INR | -682.479% |
| DECIPHER LABS LIMITED | 117.72 Million INR | -318.846% |
| Gujarat Themis Biosyn Limited | 197.37 Million INR | -149.825% |
| Ambalal Sarabhai Enterprises Limited | 1.13 Billion INR | 56.399% |
| Mercury Laboratories Limited | 171.18 Million INR | -188.037% |
| Gennex Laboratories Limited | 535.21 Million INR | 7.871% |
| BDH Industries Limited | 312.53 Million INR | -57.77% |
| Coral Laboratories Limited | 281.83 Million INR | -74.953% |
| Concord Drugs Limited | 249.88 Million INR | -97.325% |
| Bharat Parenterals Limited | 2.65 Billion INR | 81.438% |
| Beryl Drugs Limited | 85.63 Million INR | -475.794% |
| Vista Pharmaceuticals Limited | 175.16 Million INR | -181.495% |
| Evoq Remedies Limited | 116.23 Million INR | -324.227% |
| Add-Shop E-Retail Limited | 159.2 Million INR | -209.72% |
| Transchem Limited | 6.72 Million INR | -7237.604% |
| Ishita Drugs and Industries Limited | 8.87 Million INR | -5457.789% |
| Parnax Lab Limited | 1.17 Billion INR | 57.881% |
| Source Natural Foods and Herbal Supplements Limited | 41.97 Million INR | -1074.8% |
| Kerala Ayurveda Limited | 1.05 Billion INR | 53.379% |
| Cian Healthcare Limited | 1.03 Billion INR | 52.329% |
| Trinity League India Limited | 876 Thousand INR | -56188.47% |
| Syschem (India) Limited | 1.07 Billion INR | 53.948% |
| KOBO BIOTECH LIMITED | 2.04 Billion INR | 75.865% |
| Natural Capsules Limited | 1.47 Billion INR | 66.62% |
| Auro Laboratories Limited | 433.09 Million INR | -13.851% |